Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/glycogen synthase-3 kinase/ -catenin pathway
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/glycogen synthase-3 kinase/ -catenin pathway
Authors
Keywords
-
Journal
NEURO-ONCOLOGY
Volume 15, Issue 11, Pages 1502-1517
Publisher
Oxford University Press (OUP)
Online
2013-07-30
DOI
10.1093/neuonc/not104
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells
- (2012) Tor-Christian Aase Johannessen et al. NEURO-ONCOLOGY
- Glioma Stem Cells: Their Role in Chemoresistance
- (2012) Ryosuke Yamada et al. World Neurosurgery
- FoxM1 Promotes β-Catenin Nuclear Localization and Controls Wnt Target-Gene Expression and Glioma Tumorigenesis
- (2011) Nu Zhang et al. CANCER CELL
- The ABCG2 resistance network of glioblastoma
- (2011) Anne-Marie Bleau et al. CELL CYCLE
- Chemoresistance of glioblastoma cancer stem cells - much more complex than expected
- (2011) Dagmar Beier et al. Molecular Cancer
- Neural stem/progenitors and glioma stem-like cells have differential sensitivity to chemotherapy
- (2011) X. Gong et al. NEUROLOGY
- Molecular targeting of glioblastoma: Drug discovery and therapies
- (2011) Ren-Yuan Bai et al. TRENDS IN MOLECULAR MEDICINE
- Antigenic and Genotypic Similarity between Primary Glioblastomas and Their Derived Neurospheres
- (2011) Valentina Caldera et al. Journal of Oncology
- PLAGL2 Regulates Wnt Signaling to Impede Differentiation in Neural Stem Cells and Gliomas
- (2010) Hongwu Zheng et al. CANCER CELL
- -Secretase Inhibitors Enhance Temozolomide Treatment of Human Gliomas by Inhibiting Neurosphere Repopulation and Xenograft Recurrence
- (2010) C. A. Gilbert et al. CANCER RESEARCH
- Primary brain tumors, neural stem cell, and brain tumor cancer cells: Where is the link?
- (2010) Isabelle Germano et al. NEUROPHARMACOLOGY
- Enhanced MDR1 Expression and Chemoresistance of Cancer Stem Cells Derived from Glioblastoma
- (2009) Eiichi Nakai et al. CANCER INVESTIGATION
- Digoxin and ouabain increase the synthesis of cholesterol in human liver cells
- (2009) I. Campia et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Flow Cytometry Analysis of Neural Differentiation Markers Expression in Human Glioblastomas May Predict Their Response to Chemotherapy
- (2009) Vladimir Balik et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
- (2009) Bryan T. MacDonald et al. DEVELOPMENTAL CELL
- Glioblastoma multiforme: a review of where we have been and where we are going
- (2009) Cory Adamson et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas
- (2009) Daniel Bexell et al. INTERNATIONAL JOURNAL OF CANCER
- Cytotoxic Effects of Temozolomide and Radiation are Additive- and Schedule-Dependent
- (2009) Anthony J. Chalmers et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Highly infiltrative brain tumours show reduced chemosensitivity associated with a stem cell-like phenotype
- (2009) T.-C. A. Johannessen et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/β-catenin pathway
- (2009) M Flahaut et al. ONCOGENE
- A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients
- (2008) M. Schaich et al. ANNALS OF ONCOLOGY
- CD133 identifies perivascular niches in grade II–IV astrocytomas
- (2008) Karina Christensen et al. JOURNAL OF NEURO-ONCOLOGY
- New (alternative) temozolomide regimens for the treatment of glioma
- (2008) Wolfgang Wick et al. NEURO-ONCOLOGY
- Glioma Stem Cells: A Midterm Exam
- (2008) Charles D. Stiles et al. NEURON
- Gliotypic Neural Stem Cells Transiently Adopt Tumorigenic Properties During Normal Differentiation
- (2008) Noah M. Walton et al. STEM CELLS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started